DZ Bank
PRAH

DZ Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History

DZ Bank’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-650
Closed -$64K – 812
2019
Q2 		$64K Sell
650
-243,197
-100% -$23.2M ﹤0.01% 722
2019
Q1 		$26.9M Sell
243,847
-1,309,582
-84% -$137M 0.09% 149
2018
Q4 		$138M Sell
1,553,429
-83,886
-5% -$8.49M 0.54% 51
2018
Q3 		$180M Buy
1,637,315
+200,528
+14% +$20.9M 0.64% 47
2018
Q2 		$134M Buy
1,436,787
+21,096
+1% +$1.82M 0.5% 57
2018
Q1 		$111M Sell
1,415,691
-57,922
-4% -$5.15M 0.43% 65
2017
Q4 		$134M Sell
1,473,613
-25,920
-2% -$2.16M 0.51% 55
2017
Q3 		$114M Buy
1,499,533
+518,951
+53% +$39.2M 0.47% 61
2017
Q2 		$73.6M Buy
+980,582
New +$68M 0.34% 83

Other funds holding PRAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

DZ Bank's PRAH Position: Q3 2019 in Review

DZ Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 650 shares — an estimated $64K sold.

DZ Bank first reported a position in PRAH in Q2 2017 and held it in 9 quarters. The position peaked at $180M in Q3 2018. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • DZ Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • DZ Bank sold 650 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $64K.
  • DZ Bank first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 9 quarters.
  • DZ Bank's PRA Health Sciences, Inc. position peaked at $180M in Q3 2018.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on DZ Bank's 13F filing for Q3 2019, filed 14 Nov 2019.